PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...


Founded in 2021, 5Metis is a pure‐play discovery agrichemical company resulting from the union of the former Boragen, Inc. and AgriMetis, LLC agrichemical platforms. The company is focused on the discovery of new molecules with novel modes of action by combining boron‐based small molecule discovery and natural product synthetic biology.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.